Video

Q&A With W. Frank Peacock IV From Baylor College of Medicine: Taking a Closer Look at Benefits and Risks of Rivaroxaban

Author(s):

As oral anticoagulants become more popular and a new generation of the drugs is introduced there are still some questions about the potential risks of taking the medication and whether they outweigh the benefits.

As oral anticoagulants become more popular and a new generation of the drugs is introduced there are still some questions about the potential risks of taking the medication and whether they outweigh the benefits.

W. Frank Peacock IV, MD, from the Baylor College of Medicine discussed this balancing act for doctors during the European Society of Cardiology's annual congress in London.

Patients who take oral anticoagulants are always made aware of potential bleeding risks that come with the medication. How doctors approach those risks and move forward can determine a patient's understanding of their condition in their daily lives.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.